Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
4.87%
Grew
—
—
Shrank
—
1 Year
Score—
Net Growth4.87%
Net TrendGrew
Net Income Consistency—
Rev Growth—
Rev TrendShrank
Revenue Consistency—
5 Years
—
-58.01%
40%
—
—
Never
—
5 Years
Score—
Net Growth-58.01%
Net Trend40%
Net Income Consistency—
Rev Growth—
Rev TrendNever
Revenue Consistency—
Achieve Life Sciences Inc fundamental performance
Between 2005 and 2025, revenue declined from $ 8M to $ 0.00 and net income went from -$ 21M to -$ 54M. Revenue increased in 4 of those 20 years; net income in 9.
Across Achieve Life Sciences Inc's full reported history, from 1995 to 2025, revenue declined from $ 4M to $ 0.00 and net income went from -$ 5M to -$ 54M. Revenue increased in 32% of the years measured; net income in 42%.
Achieve Life Sciences Inc currently holds a 20-year HDB Score of 1.8 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 6.69 | — |
1 Year2025-08-12 | $ 2.44 | 174.18% |
5 Years2021-08-12 | $ 7.57 | -11.57% |
10 Years2016-08-12 | $ 1.91K | -99.65% |
20 Years2006-08-11 | $ 188.1K | -100.00% |
30 Years1996-08-12 | $ 678.15K | -100.00% |
All Time1995-10-13 | $ 282.15K | -100.00% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | 20 Years2006-08-11 | 30 Years1996-08-12 | All Time1995-10-13 |
|---|---|---|---|---|---|---|---|
| Price | $ 6.69 | $ 2.44 | $ 7.57 | $ 1.91K | $ 188.1K | $ 678.15K | $ 282.15K |
| Return | — | 174.18% | -11.57% | -99.65% | -100.00% | -100.00% | -100.00% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 0.00 | -$ 51M | $ 29M |
| 2025 | $ 0.00 | -$ 54M | $ 36M |
| 2024 | $ 0.00 | -$ 39M | $ 34M |
| 2023 | $ 0.00 | -$ 29M | $ 15M |
| 2022 | $ 0.00 | -$ 41M | $ 24M |
| 2021 | $ 0.00 | -$ 32M | $ 43M |
| 2020 | $ 0.00 | -$ 14M | $ 35M |
| 2019 | $ 0.00 | -$ 16M | $ 16M |
| 2018 | $ 0.00 | -$ 12M | $ 14M |
| 2017 | $ 0.00 | -$ 10M | $ 5M |
| 2016 | $ 5M | -$ 20M | $ 25M |
| 2015 | $ 18M | -$ 16M | $ 55M |
| 2014 | $ 27M | -$ 26M | $ 47M |
| 2013 | $ 29M | -$ 31M | $ 39M |
| 2012 | $ 20M | -$ 21M | $ 75M |
| 2011 | $ 5M | -$ 14M | $ 64M |
| 2010 | $ 13M | -$ 12M | $ 85M |
| 2009 | $ 25M | $ 5M | $ 64M |
| 2008 | $ 20M | -$ 4M | $ 13M |
| 2007 | $ 20M | -$ 13M | $ 34M |
| 2006 | $ 22M | -$ 23M | $ 58M |
| 2005 | $ 8M | -$ 21M | $ 49M |
| 2004 | $ 264M | -$ 16M | $ 20M |
| 2003 | $ 25K | -$ 10M | $ 19M |
| 2002 | $ 25K | -$ 11M | $ 16M |
| 2001 | $ 8M | $ 542.18K | $ 15M |
| 2000 | $ 408.41K | -$ 2M | $ 13M |
| 1999 | $ 12M | $ 400K | $ 16M |
| 1998 | $ 5M | -$ 11M | $ 17M |
| 1997 | $ 18M | $ 1M | $ 5M |
| 1996 | $ 16M | $ 1M | $ 7M |
| IPO1995 | $ 4M | -$ 5M | $ 5M |
Explore beyond ACHV
You're looking at Achieve Life Sciences Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
